| 25 May 2026 |
Dermorphin |
4.0 |
20mg |
21.0mg |
+5.1% |
96.58% |
Lab D |
| 25 May 2026 |
Halotestin (Fluoxymesterone) |
4.0 |
50mg |
49.1mg |
-1.7% |
98.08% |
Lab E |
| 25 May 2026 |
PTD-DBM |
4.0 |
20mg |
22.9mg |
+14.6% |
98.12% |
Lab F |
| 25 May 2026 |
Testosterone Cypionate Raw |
6.7 |
500g |
503.1g |
+0.6% |
99.67% |
Lab B |
| 25 May 2026 |
Testosterone Cypionate Raw |
5.8 |
10g |
10.4g |
+3.5% |
97.49% |
Lab G |
| 24 May 2026 |
Thymalin |
5.7 |
2mg |
2.3mg |
+15.5% |
96.66% |
Lab C |
| 24 May 2026 |
Dapoxetine |
4.2 |
20mg |
23.3mg |
+16.4% |
99.90% |
Lab C |
| 24 May 2026 |
Sleep Blend (GABA 100mg+Histidine 100mg+L-Theanine 50mg+Taurine 100mg+Melatonin 2mg) |
6.2 |
300mg/ml |
352.1mg/ml |
+17.4% |
98.01% |
Lab B |
| 24 May 2026 |
Dermorphin |
6.1 |
30mg |
30.0mg |
-0.1% |
98.92% |
Lab B |
| 24 May 2026 |
PTD-DBM |
4.0 |
10mg |
11.2mg |
+11.8% |
99.76% |
Lab F |
| 24 May 2026 |
YK-11 Raw |
4.0 |
5g |
5.8g |
+16.0% |
98.62% |
Lab C |
| 24 May 2026 |
ANPP (4-anilino-N-phenethylpiperidine) CAS 21409-26-7 |
4.0 |
5g |
6.1g |
+22.8% |
96.99% |
Lab C |
| 24 May 2026 |
P-2-P (phenyl-2-propanone / BMK) CAS 103-79-7 |
5.1 |
5g |
4.7g |
-5.4% |
97.67% |
Lab C |
| 24 May 2026 |
Thymalin |
4.7 |
5mg |
5.4mg |
+7.8% |
96.91% |
Lab C |
| 23 May 2026 |
AICAR |
5.5 |
30mg |
26.5mg |
-11.8% |
97.58% |
Lab C |
| 23 May 2026 |
BPC 500mcg + TB500 500mcg Blend Oral |
4.0 |
50mg |
62.1mg |
+24.1% |
97.17% |
Lab F |
| 23 May 2026 |
Lipo-B 216mg |
4.0 |
200mg/ml |
181.9mg/ml |
-9.1% |
98.57% |
Lab A |
| 23 May 2026 |
SNAP-8 |
4.3 |
5mg |
4.3mg |
-14.7% |
96.61% |
Lab D |
| 23 May 2026 |
BPC 500mcg + TB500 500mcg Blend Oral |
4.0 |
20mg |
19.0mg |
-5.0% |
96.85% |
Lab E |
| 23 May 2026 |
DNP |
7.0 |
100mg |
117.5mg |
+17.5% |
96.88% |
Lab D |
| 21 May 2026 |
ANPP (4-anilino-N-phenethylpiperidine) CAS 21409-26-7 |
5.2 |
10g |
8.9g |
-10.8% |
98.70% |
Lab A |
| 21 May 2026 |
Dapoxetine |
5.7 |
25mg |
28.0mg |
+12.2% |
98.10% |
Lab G |
| 21 May 2026 |
Minoxidil Oral |
7.0 |
10mg |
11.8mg |
+17.5% |
97.54% |
Lab F |
| 21 May 2026 |
P-2-P (phenyl-2-propanone / BMK) CAS 103-79-7 |
6.0 |
5g |
5.2g |
+3.4% |
98.53% |
Lab F |
| 20 May 2026 |
MOTS-C |
6.4 |
15mg |
13.2mg |
-12.2% |
96.33% |
Lab F |
| 19 May 2026 |
Cardiogen |
7.2 |
20mg |
18.6mg |
-7.1% |
96.66% |
Lab E |
| 17 May 2026 |
Sleep Blend (GABA 100mg+Histidine 100mg+L-Theanine 50mg+Taurine 100mg+Melatonin 2mg) |
6.0 |
300mg/ml |
282.4mg/ml |
-5.9% |
96.97% |
Lab F |
| 29 Jan 2026 |
Lipo-B 216mg |
4.0 |
100mg/ml |
93.1mg/ml |
-6.9% |
99.03% |
Lab B |
| 29 Jan 2026 |
Winstrol Oil |
6.2 |
200mg/ml |
230.0mg/ml |
+15.0% |
97.44% |
Lab G |
| 26 Jan 2026 |
AICAR |
4.0 |
20mg |
24.2mg |
+21.1% |
97.72% |
Lab A |
| 26 Jan 2026 |
Sleep Blend (GABA 100mg+Histidine 100mg+L-Theanine 50mg+Taurine 100mg+Melatonin 2mg) |
4.0 |
250mg/ml |
258.0mg/ml |
+3.2% |
98.58% |
Lab A |
| 19 Jan 2026 |
Dapoxetine |
6.1 |
100mg |
115.5mg |
+15.5% |
99.19% |
Lab G |
| 19 Jan 2026 |
YK-11 Raw |
4.4 |
500g |
596.3g |
+19.3% |
98.95% |
Lab B |
| 9 Jan 2026 |
Bronchogen |
5.5 |
15mg |
13.2mg |
-12.1% |
97.01% |
Lab G |
| 7 Jan 2026 |
Vesugen |
4.0 |
2mg |
2.2mg |
+12.0% |
99.63% |
Lab D |
| 6 Jan 2026 |
Testosterone Cypionate Raw |
6.3 |
100g |
114.0g |
+14.0% |
96.18% |
Lab D |
| 29 Dec 2025 |
DSIP |
4.4 |
50mg |
52.4mg |
+4.8% |
99.45% |
Lab B |
| 12 Dec 2025 |
DNP |
4.2 |
50mg |
49.1mg |
-1.9% |
97.80% |
Lab A |
| 5 Dec 2025 |
Lipo-B 216mg |
5.0 |
250mg/ml |
308.6mg/ml |
+23.4% |
97.11% |
Lab F |
| 5 Dec 2025 |
Pinealon |
7.2 |
15mg |
16.6mg |
+11.0% |
97.29% |
Lab F |
| 5 Dec 2025 |
Vesugen |
6.9 |
30mg |
35.2mg |
+17.4% |
99.77% |
Lab B |
| 23 Nov 2025 |
ANPP (4-anilino-N-phenethylpiperidine) CAS 21409-26-7 |
4.0 |
100g |
100.0g |
-0.0% |
99.93% |
Lab G |
| 23 Nov 2025 |
Methylene Blue |
4.5 |
25mg |
25.6mg |
+2.4% |
98.98% |
Lab E |
| 23 Nov 2025 |
Semax |
7.9 |
5mg |
5.1mg |
+1.8% |
96.18% |
Lab F |
| 23 Nov 2025 |
Semax |
4.4 |
20mg |
23.4mg |
+17.2% |
98.62% |
Lab C |
| 14 Nov 2025 |
DSIP |
7.5 |
50mg |
48.2mg |
-3.7% |
95.50% |
Lab C |
| 5 Nov 2025 |
AICAR |
4.8 |
50mg |
54.4mg |
+8.7% |
97.22% |
Lab A |
| 5 Nov 2025 |
Methylene Blue |
4.0 |
20mg |
23.6mg |
+18.2% |
95.28% |
Lab A |
| 5 Nov 2025 |
Minoxidil Oral |
8.0 |
10mg |
11.2mg |
+11.7% |
98.28% |
Lab A |
| 5 Nov 2025 |
P-2-P (phenyl-2-propanone / BMK) CAS 103-79-7 |
4.8 |
1g |
1.1g |
+7.9% |
95.48% |
Lab G |
| 5 Nov 2025 |
Semax |
6.6 |
10mg |
9.3mg |
-6.8% |
96.14% |
Lab D |
| 5 Nov 2025 |
T3 (Liothyronine) |
5.9 |
10mg |
8.7mg |
-13.4% |
99.17% |
Lab D |
| 5 Nov 2025 |
Vesugen |
7.2 |
2mg |
1.8mg |
-10.9% |
95.13% |
Lab C |
| 4 Nov 2025 |
Halotestin (Fluoxymesterone) |
4.0 |
10mg |
8.6mg |
-13.6% |
96.91% |
Lab F |
| 17 Oct 2025 |
DSIP |
4.1 |
5mg |
5.2mg |
+3.4% |
98.31% |
Lab A |
| 17 Oct 2025 |
Thymalin |
4.4 |
30mg |
31.1mg |
+3.8% |
99.22% |
Lab D |
| 9 Oct 2025 |
PTD-DBM |
4.6 |
2mg |
2.0mg |
-2.2% |
98.97% |
Lab F |
| 9 Oct 2025 |
YK-11 Raw |
4.6 |
5g |
5.0g |
+0.4% |
95.02% |
Lab B |
| 3 Oct 2025 |
BAC Water |
6.8 |
10mg |
11.3mg |
+12.9% |
97.33% |
Lab B |
| 3 Oct 2025 |
SNAP-8 |
6.9 |
30mg |
27.0mg |
-9.8% |
96.90% |
Lab A |
| 3 Oct 2025 |
Winstrol Oil |
6.2 |
300mg/ml |
264.4mg/ml |
-11.9% |
99.38% |
Lab E |
| 7 May 2025 |
Tirzepatide |
|
4.2 |
5mg |
4.42mg |
-11.6% |
White Label / Silver Crimp / Black Cap |
| 7 May 2025 |
Tirzepatide |
|
7.8 |
10mg |
9.48mg |
-5.2% |
White Label / Silver Crimp / Purple Cap |
| 6 May 2025 |
Retatrutide |
|
6.0 |
5mg |
5.6mg |
+12.0% |
White Label / Silver Crimp / Violet Cap |
| 5 May 2025 |
CJC-1295 |
DAC |
1.3 |
2mg |
1.16mg |
-42.0% |
White Label / Silver Crimp / Red Cap |
| 5 May 2025 |
CJC-1295 |
DAC |
1.1 |
2mg |
0.93mg |
-53.5% |
White Label / Silver Crimp / Red Cap |
| 5 May 2025 |
BPC-157 |
|
4.1 |
5mg |
4.05mg |
-19.0% |
White Label / Silver Crimp / Purple Cap |
| 27 Mar 2025 |
Retatrutide |
|
8.0 |
5mg |
5.07mg |
+1.4% |
White Label / Silver Crimp / Violet Cap |